Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.

@article{Ruhlmann1997FluorodeoxyglucoseWP,
  title={Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.},
  author={J{\"u}rgen Ruhlmann and Axel G. Schomburg and H Eric Bender and Peter Oehr and G.-M. Robertz-Vaupel and Hannah Vaupel and Hubertus Wolter and Beate Kozak and H. J. Biersack},
  journal={Diseases of the colon and rectum},
  year={1997},
  volume={40 10},
  pages={1195-204}
}
PURPOSE To evaluate the routine clinical value of attenuation-corrected whole-body fluorodeoxyglucose positron emission tomography in colorectal cancer, a total of 59 patients who were referred for evaluation of suspected or proven colorectal cancers were studied. METHODS Positron emission tomography scans were recorded using a Siemens ECAT Exact 921/47. RESULTS Median follow-up after the positron emission tomography study was 11 (mean, 12.3; range, 1-21) months. According to computed… CONTINUE READING